Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars
ROCKVILLE, Md., Aug 24, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today hosted “Looking Beyond the Bench,” a symposium organized for doctoral students enrolled in the NIH-Oxford-Cambridge Scholars Program. The symposium featured Emergent executives, who, based on their extensive experience in the biopharmaceutical industry, [...]
August 30, 2010
Tags: Anthrax vaccines, BioSolutions Inc, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, fuad el-hibri, Infectious disease, Scholars Program Posted in: Anthrax vaccines, Biosolutions, Business, El-Hibri Peace Education Prize, Emergent BioSolutions, Infectious disease, Scholars Program, fuad el-hibri
No Comments
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility
ROCKVILLE, MD, July 16, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon cutting ceremony, led by Governor Martin O’Malley and Fuad El-Hibri, Emergent’s chairman and chief executive officer, to mark the formal opening of Emergent Manufacturing Operations [...]
July 27, 2010
Tags: Chief executive officer, Emergent BioSolutions, Employment, fuad el-hibri, Martin O'Malley, Maryland, United States. Posted in: Emergent BioSolutions, Health Care, fuad el-hibri
No Comments
Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland
ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards. This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]
May 18, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, fuad el-hibri, Research and development, Tech Council of Maryland Posted in: CEO, Department of Health and Human Services, Emergent BioSolutions, Research and development, Tech Council of Maryland, fuad el-hibri
No Comments
Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly
Emergent BioSolutions’ senior management team, headed by Fuad El-Hibri, chairman and chief executive officer and Daniel J. Abdun-Nabi, president and chief operating officer, are hosting “Bioterrorism Prevention, Preparedness and Response,” a forum uniquely organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA). The one-day event is an interactive discussion related to [...]
May 11, 2010
Tags: Chief executive officer, Emergent BioSolutions, fuad el-hibri, Hudson Institute, NATO, North Atlantic Treaty Organization, United States Department of Defense, United States. Posted in: Emergent BioSolutions, Hudson Institute, North Atlantic Treaty Organization, United States Department of Defense, fuad el-hibri
No Comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
March 15, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Leadership, Maryland Posted in: Biosolutions, Business, Emergent BioSolutions, Management
No Comments
Emergent BioSolutions reacts to BARDA’s Request for Proposal cancellation
by Nick Rees on December 8, 2009
Fuad El-Hibri
The Office of the Biomedical Advanced Research and Development Authority has advised Emergent BioSolutions that while BARDA’s Request for Proposal has been canceled, Emergent is encouraged to submit a proposal for the office’s Broad Agency Announcement.
BARDA canceled the RFP for the procurement for rPA vaccines after [...]
December 15, 2009
Tags: Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, Chief executive officer, Emergent BioSolutions, Federal government of the United States, fuad el-hibri, Strategic National Stockpile, United States. Posted in: BARDA, Biosolutions, CEO, Department of Health and Human Services, Emergent BioSolutions, Maryland, fuad el-hibri
No Comments
Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
Executives
Robert G. Burrows – Vice President, Investor Relations
Fuad El-Hibri – Chairman of the Board, Chief Executive Officer
R. Don Elsey – Chief Financial Officer
Daniel J. Abdun-Nabi – President, Chief Operating Officer
W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer
Analysts
Eric Schmidt [...]
August 14, 2009
Tags: Business, Chairman, Chief executive officer, Chief financial officer, Chief operating officer, Emergent BioSolutions, finance, fuad el-hibri, Investor relations, Shareholders, US government, Vice president Posted in: Board of Directors, CEO, Emergent BioSolutions, Management, Shareholders, fuad, fuad el-hibri
No Comments
STATEMENT BY FUAD EL-HIBRI, EMERGENT BIOSOLUTIONS CHAIRMAN AND CHIEF EXECUTIVE OFFICER, ON THE PASSING OF ADMIRAL WILLIAM CROWE, JR., FORMER BOARD MEMBER.
ROCKVILLE, MD, October 19, 2007— Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions, issued the following statement on the passing of Admiral William Crowe, Jr., who served on the company’s Board of Directors from 1998-2005.
“I was deeply saddened to learn of the passing of my dear friend and former colleague, the honorable Admiral [...]
July 15, 2009
Tags: Anthrax vaccines, Board of Directors, Chief executive officer, Emergent BioSolutions, Health, Infectious disease, United States., US Food and Drug Administration. Posted in: Uncategorized
No Comments
Emergent Biosolutions Appoints Dr. W. James Jackson As Chief Scientific Officer
Emergent BioSolutions Inc. (NYSE: EBS) announced today that W. James Jackson, Ph.D., has been appointed chief scientific officer, effective immediately. Dr. Jackson will report directly to Fuad El-Hibri, chairman and chief executive officer.
As CSO, Dr. Jackson will lead the company’s scientific evaluation of new products and technology platforms and will be responsible for building and [...]
July 13, 2009
Tags: Anthrax vaccines, Biotechnology and Pharmaceuticals, Business, Chief executive officer, Infectious disease, Pharmaceutical, Research and development, U.S. Food and Drug Administration, University of Georgia. Posted in: Uncategorized
No Comments
Emergent Biosolutions And Ninebio Sdn. Bhd. Announce Joint Venture In Malaysia
Newly formed company to focus on creating critical R&D and manufacturing infrastructure and supplying biodefense countermeasures within Asia and other territories.
January 24, 2008 – Emergent BioSolutions (NYSE: EBS) and Ninebio Sdn. Bhd. (“9Bio”) today announced the formation of a joint venture in Malaysia that will focus on creating critical biologics infrastructure and supplying biodefense countermeasures, [...]
July 13, 2009
Tags: Business, Chief executive officer, Emergent BioSolutions, MALAYSIA, National Institutes of Health, Private Securities Litigation Reform Act, Research and development, SEC, U.S. Food and Drug Administration, United States. Posted in: Uncategorized
No Comments
